Concepedia

Anti–Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema

Mathilde Leclercq, Anaïs Andrillon, Georgina Maalouf, P. Sève, P. Bielefeld, J. Gueudry, Thomas Sené, T. Moulinet, Bénédicte Rouvière, D. Sène,

Ophthalmology · 2021 · 76 citations · 26 references

DOIFull text

Open access

Concepts

References

26

Standardizatlon of Vitreal inflammatory Activity in Intermediate and Posterior Uveitis

Robert B. Nussenblatt, Alan G. Palestine, Chi‐Chao Chan et al. · Ophthalmology · 1985 · 681 citations

, , +13

Adalimumab in Patients with Active Noninfectious Uveitis

Glenn J. Jaffe, Andrew D. Dick, Antoine P. Brézin et al. · New England Journal of Medicine · 2016 · 659 citations · Full text

, , +17

Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial

Quan Dong Nguyen, Pauline T. Merrill, Glenn J. Jaffe et al. · The Lancet · 2016 · 512 citations · Full text

, , +16

Prevalence of Noninfectious Uveitis in the United States

Jennifer E. Thorne, Eric B. Suhler, Martha Skup et al. · JAMA Ophthalmology · 2016 · 263 citations · Full text

, , +15

Treatment of Refractory Uveitis with Adalimumab: A Prospective Multicenter Study of 131 Patients

M. Díaz-Llopis, David Salom, Carmen García-De-Vicuña et al. · Ophthalmology · 2012 · 231 citations · Full text

, , +13